Education
About Us
Working with TipRanks
Follow Us
Bobak R. Azamian Insider Profile
4 Followers
Bobak R. Azamian, President/CEO and Board Chair, Director at Tarsus Pharmaceuticals, holds 877.74K shares in Tarsus Pharmaceuticals (Ticker: TARS).
Bobak R. Azamian Tarsus Pharmaceuticals (TARS)President/CEO and Board Chair, Director
Tarsus Pharmaceuticals (TARS)
President/CEO and Board Chair, Director
Ranked #98,639 out of 102,830 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-106.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Bobak R. Azamian's holdings
Insider Roles
President/CEO and Board Chair, Director
Roles that Bobak R. Azamian holds in companies
Most Profitable Insider Trade
The most profitable trade made by Bobak R. Azamian
Bobak R. Azamian's Trading History
List of latest transactions for each holding click on a transaction to see Bobak R. Azamian's performance on stock
You May Also Like
Bobak R. Azamian insider profile FAQ
What is the percentage of profitable transactions made by Bobak R. Azamian?
The percentage of profitable transactions made by Bobak R. Azamian is 33%.
What is the average return per transaction made by Bobak R. Azamian?
The average return per transaction made by Bobak R. Azamian is -106.50%.
What stocks does Bobak R. Azamian hold?
Bobak R. Azamian holds: TARS stocks.
What was Bobak R. Azamian’s latest transaction?
Bobak R. Azamian latest transaction was an Uninformative Sell of $300.00K.
What was Bobak R. Azamian's most profitable transaction?
Bobak R. Azamian’s most profitable transaction was an Informative Sell of TARS stock on March 20, 2025. The return on the trade was 18.20%.
What is Bobak R. Azamian's role in Tarsus Pharmaceuticals?
Bobak R. Azamian's role in Tarsus Pharmaceuticals is President/CEO and Board Chair, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.